102 related articles for article (PubMed ID: 20928882)
1. Studies of anti-HIV transcription inhibitor quinolones: identification of potent N1-vinyl derivatives.
Tabarrini O; Massari S; Daelemans D; Meschini F; Manfroni G; Bottega L; Gatto B; Palumbo M; Pannecouque C; Cecchetti V
ChemMedChem; 2010 Nov; 5(11):1880-92. PubMed ID: 20928882
[TBL] [Abstract][Full Text] [Related]
2. Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity.
Tabarrini O; Massari S; Sancineto L; Daelemans D; Sabatini S; Manfroni G; Cecchetti V; Pannecouque C
ChemMedChem; 2011 Jul; 6(7):1249-57. PubMed ID: 21567967
[TBL] [Abstract][Full Text] [Related]
3. Studies on anti-HIV quinolones: new insights on the C-6 position.
Massari S; Daelemans D; Manfroni G; Sabatini S; Tabarrini O; Pannecouque C; Cecchetti V
Bioorg Med Chem; 2009 Jan; 17(2):667-74. PubMed ID: 19091580
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship study on anti-HIV 6-desfluoroquinolones.
Tabarrini O; Massari S; Daelemans D; Stevens M; Manfroni G; Sabatini S; Balzarini J; Cecchetti V; Pannecouque C; Fravolini A
J Med Chem; 2008 Sep; 51(17):5454-8. PubMed ID: 18710207
[TBL] [Abstract][Full Text] [Related]
5. Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity.
He QQ; Gu SX; Liu J; Wu HQ; Zhang X; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Aug; 19(16):5039-45. PubMed ID: 21763149
[TBL] [Abstract][Full Text] [Related]
6. 6-desfluoroquinolones as HIV-1 Tat-mediated transcription inhibitors.
Tabarrini O; Massari S; Cecchetti V
Future Med Chem; 2010 Jul; 2(7):1161-80. PubMed ID: 21426162
[TBL] [Abstract][Full Text] [Related]
7. Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands.
Sancineto L; Iraci N; Barreca ML; Massari S; Manfroni G; Corazza G; Cecchetti V; Marcello A; Daelemans D; Pannecouque C; Tabarrini O
Bioorg Med Chem; 2014 Sep; 22(17):4658-66. PubMed ID: 25127466
[TBL] [Abstract][Full Text] [Related]
8. Structure modifications of 6-aminoquinolones with potent anti-HIV activity.
Tabarrini O; Stevens M; Cecchetti V; Sabatini S; Dell'Uomo M; Manfroni G; Palumbo M; Pannecouque C; De Clercq E; Fravolini A
J Med Chem; 2004 Oct; 47(22):5567-78. PubMed ID: 15481992
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication.
Bridger GJ; Skerlj RT; Hernandez-Abad PE; Bogucki DE; Wang Z; Zhou Y; Nan S; Boehringer EM; Wilson T; Crawford J; Metz M; Hatse S; Princen K; De Clercq E; Schols D
J Med Chem; 2010 Feb; 53(3):1250-60. PubMed ID: 20043638
[TBL] [Abstract][Full Text] [Related]
10. A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication.
Massari S; Daelemans D; Barreca ML; Knezevich A; Sabatini S; Cecchetti V; Marcello A; Pannecouque C; Tabarrini O
J Med Chem; 2010 Jan; 53(2):641-8. PubMed ID: 19958026
[TBL] [Abstract][Full Text] [Related]
11. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives.
Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH
Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103
[TBL] [Abstract][Full Text] [Related]
12. 2-Phenylquinolones as inhibitors of the HIV-1 Tat-TAR interaction.
Gatto B; Tabarrini O; Massari S; Giaretta G; Sabatini S; Del Vecchio C; Parolin C; Fravolini A; Palumbo M; Cecchetti V
ChemMedChem; 2009 Jun; 4(6):935-8. PubMed ID: 19283692
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
[TBL] [Abstract][Full Text] [Related]
14. Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents.
Sun IC; Wang HK; Kashiwada Y; Shen JK; Cosentino LM; Chen CH; Yang LM; Lee KH
J Med Chem; 1998 Nov; 41(23):4648-57. PubMed ID: 9804704
[TBL] [Abstract][Full Text] [Related]
15. New quinolone antibiotics: a survey of the literature from 2005 to 2010.
Wiles JA; Bradbury BJ; Pucci MJ
Expert Opin Ther Pat; 2010 Oct; 20(10):1295-319. PubMed ID: 20645884
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 3,4-dihydropyrimidin-2(1H)-ones with inhibitory activity against HIV-1 replication.
Kim J; Park C; Ok T; So W; Jo M; Seo M; Kim Y; Sohn JH; Park Y; Ju MK; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Sommer P; No Z
Bioorg Med Chem Lett; 2012 Mar; 22(5):2119-24. PubMed ID: 22305583
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
[TBL] [Abstract][Full Text] [Related]
18. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
[TBL] [Abstract][Full Text] [Related]
19. Development of new potent and selective agents against HIV (human immunodeficiency virus).
Pauwels R; Schols D
Verh K Acad Geneeskd Belg; 1991; 53(6):629-55. PubMed ID: 1816706
[TBL] [Abstract][Full Text] [Related]
20. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus.
Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK
Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
